Summary:
This manuscript details a prospective study of diagnostic and prognostic variables among children and adolescents at risk of developing persistent post-concussive symptoms following mTBI from blunt trauma. The study addresses an important problem in the mTBI literature and is rigorously designed to obtain the specified objective. Psychosocial, genetic and injury factors are included as candidate variables and the primary outcome (PCS) is the most clinically relevant for front-line providers; this will make the study broadly applicable. There are only minor concerns with inclusion and exclusion criteria but these are insufficient to undermine any potential success of the study. The study authors include several internationally recognized pediatric mTBI experts, several with individual success at running large observational studies. The study is likely to be successful in contributing a significant amount of generalizable knowledge to our understanding of pediatric mTBI.
Introduction:
The introduction is written succinctly and gives appropriate context on the current state of scientific knowledge and related gaps regarding concussion diagnosis and management (prognostication). The authors prepare the reader for the need and potential impact of the proposed study. Their assessment of the literature is not overstated. Front-line providers are truly in need of useful and reliable methods to identify children and adolescents who are most at risk of a protracted recovery course. Recent literature suggests that active rehabilitation and not strict rest may be more helpful in recovery but, in general, the data are not conclusive in either direction.
Objectives:
The objectives provided in this paragraph are clear, discrete and potentially obtainable.
Methods -Study Overview: I think it would be useful for the general reader to have a little more explanation as to why an OI comparator group is best suited for use in this study. While the sports medicine or concussion specialist may have a better sense of the appropriateness of this comparison, the general pediatrician or emergency physician may not. Perhaps calling out the general effects of trauma on symptom reporting and the non-specific nature of post-concussion symptoms may be useful. A clause or single sentence should suffice.
Methods -Study Population:
Although this is a minor point, in the Introduction the authors describe the burden of mTBI among North American children and adolescents and proceed to describe a need to study a representative sample of children with mTBI for prognostic purposes. However, the population is limited to children < 17 years old due to a convenience sampling issue (few children 17 and older present to Canadian pediatric ERs). This raises a concern that among other North American ERs, where adolescents up to the age of 22 may seek care and not represented. Developmentally and physically there is not likely to be significant differences between a 17 and 22 year old but there may be significant differences in the frequency of prior mTBI exposure which likely contributes to symptom duration. With the unavoidable drift in the application of any study findings, it is important to recognize this limitation early on.
Within the Inclusion Criteria, it is noted that children with whiplash injury are not expressly included though they may be at risk of concussion as well. Otherwise Inclusion Criteria listed are representative of common clinical practice.
Exclusion criteria are generally appropriate. However, are children requiring closed reductions using local/regional anesthesia excluded? For example, a child with a digital dislocation could be managed with a digital nerve block? Would she be eligible? Similarly, a child with a minimally angulated fracture may undergo hematoma block with the addition of nitrous oxide or intranasal fentanyl. Would he be eligible?
It is noted that the history of a prior concussion in the preceding 3 months is an exclusion. Yet the authors are studying outcomes for up to 6 months suggesting that that duration of time is, at least for some children, likely to include ongoing symptoms. A more appropriate time fame may be 6 or even 12 months as some limited data show that there is a difference in symptom persistence for subsequent concussions when the preceding concussion was more or less than 1 year prior.
Methods -Measures:
As stated in the Introduction and Study Overview, the measures obtained represent a comprehensive assessment of all domains that play a role in the expression of concussion symptoms or disposition toward sustaining a concussion. It is not clear that there is a measure of premorbid somatization tendencies which limited evidence suggest may be related to PCS reporting.
One concern is the duration and challenge of the testing strategy itself. Specifically, how will 90-120 minutes of testing influence some of the reported parameters among a population where cognitive exertion may exacerbate findings? Perhaps, this is another benefit of the orthopedic control group and therefore, a moot point.
Methods -Data Management:
No concerns noted.
Methods -Data Analysis:
The primary outcome is clinically relevant for the emergency clinician and outpatient providers. As symptoms are the primary indicator for determining most management and referral decisions, this appropriately drives how predictor variables are assessed and controlled.
It is recommended that specific statistical expertise in accounting for missing data and prognostic analysis procedures also review this protocol.
Ethics and Dissemination:
There are no ethical concerns for the protocol as presented. Autonomy, beneficence and respect for persons are all maintained.
The Dissemination Plan lacks some detail as to how results will be supplied to end users (bedside providers, policy drivers, professional societies) beyond traditional scientific results dissemination channels. Further description of the use of a "knowledge broker" in this document would be welcome if space permits
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GENERAL COMMENTS
The article entitled "The Advancing Concussion Assessment in Pediatrics (A-CAP) study: Protocol for a prospective, concurrent cohort, longitudinal study of mild traumatic brain injury in children." submitted by Yates et al. describes a protocol that is being implemented across five pediatric research centers across Canada to identify predictors of ongoing symptoms of PCS following mTBI. This group has recently published a number of seminal reports identifying factors predictive of ongoing symptoms of PCS following mTBI from data collected at the initial emergency room visit. They are now conducting a longitudinal study to follow approximately 700 subjects with mTBI as compared them with 300 subjects following orthopedic injury who will be recruited between September, 2016 and August, 2018.
This manuscript is not a research report. Rather it is a detailed summary of their study protocol. As such it provides a description and discussion of the plan for their study. Concerns regarding the study design include:
1)
Following mTBI approximately 80% of subjects will return to baseline within 4-8 weeks. The focus of the genetic and imaging studies will therefore need to be on the 20% who will have ongoing symptoms.
2)
In that regard the known predictors of ongoing symptoms include a history of anxiety and somatization which do not appear to be independently assessed using the most standardized neuropsychologic instruments (e.g., BAI-Y; BSI-18, respectively).
3)
The second MRI may not be warranted on subjects whose symptoms resolve in the first 2 to 4 weeks, who have normal MRIs at the first time point.
4)
These investigators are appropriately looking for a history of headaches and migraines, as well as attention deficit and learning disability, which are independent predictors of adverse outcomes. However, two of the other known predictors of adverse outcomes following mTBI do not appear to be independently assessed. Since it has been shown that individuals with vestibulo-ocular deficits, as well as cervico-genic complications have prolonged symptoms of PCS, those assessments need to be made.
5)
In a related concern, it would be important to identify the potential efficacy of any parallel therapy that each subject may be receiving. As mentioned, given the relevance of ongoing anxiety, vestibulo-ocular deficits, and cervico-genic pain in contributing to longer recovery periods, such subjects are often treated with ongoing behavioral therapy, vestibular therapy, and neck physical therapy, respectively. Subjects who receive such therapies will need to be identified, and have that information entered as a covariate, to establish the potential efficacy of such interventions in remediating ongoing symptoms.
In summary, this report describes the protocol for a much needed study, which is comprehensive in design, and significant in the numbers of subjects to be recruited. Attention to some of the issues above is may provide "value added" to the study.
VERSION 1 -AUTHOR RESPONSE
Reviewer 1 1) I think it would be useful for the general reader to have a little more explanation as to why an OI comparator group is best suited for use in this study. Perhaps calling out the general effects of trauma on symptom reporting and the non-specific nature of post-concussion symptoms may be useful. A clause or single sentence should suffice.
Response: The reviewer may have overlooked the following sentence, which is in the first paragraph of the Study Overview: "Children with OI were chosen as a comparison group because they are comparable to children with mTBI demographically and in terms of background characteristics that may affect outcomes17, and also because they share a common exposure to a traumatic injury."
2) Although this is a minor point, in the Introduction the authors describe the burden of mTBI among North American children and adolescents and proceed to describe a need to study a representative sample of children with mTBI for prognostic purposes. However, the population is limited to children < 17 years old due to a convenience sampling issue (few children 17 and older present to Canadian pediatric ERs). This raises a concern that among other North American ERs, where adolescents up to the age of 22 may seek care and not represented. Developmentally and physically there is not likely to be significant differences between a 17 and 22 year old but there may be significant differences in the frequency of prior mTBI exposure which likely contributes to symptom duration. With the unavoidable drift in the application of any study findings, it is important to recognize this limitation early on.
Response: The choice to restrict our focus to ages 8-16.99 was not entirely one of convenience. The focus of the study is on children and adolescents, and not on young adults. Thus, we do not see the exclusion of individuals 17 and older as a significant limitation, and have clarified our rationale in that regard. When we disseminate our findings, we will certainly stress that they are only applicable to the age range studied.
3) Within the Inclusion Criteria, it is noted that children with whiplash injury are not expressly included though they may be at risk of concussion as well.
Response: Children with whiplash are neither expressly included nor expressly excluded. If a child with a whiplash injury meets the criteria for inclusion in the concussion group, they are included. 4) Exclusion criteria are generally appropriate. However, are children requiring closed reductions using local/regional anesthesia excluded? For example, a child with a digital dislocation could be managed with a digital nerve block? Would she be eligible? Similarly, a child with a minimally angulated fracture may undergo hematoma block with the addition of nitrous oxide or intranasal fentanyl. Would he be eligible? Response: Although a child who was treated only with local or regional anesthesia for a closed reduction could be included in theory, in practice our Emergency Departments would use procedural sedation in all such cases. Thus the first child would be excluded in virtually all instances. We consider nitrous oxide to be procedural sedation and its use would exclude a child. IN fentanyl would not exclude a child if used for pain and not accompanied by a sedative. We have modified the text to clarify the relevant exclusion criterion.
5) It is noted that the history of a prior concussion in the preceding 3 months is an exclusion. Yet the authors are studying outcomes for up to 6 months suggesting that that duration of time is, at least for some children, likely to include ongoing symptoms. A more appropriate time fame may be 6 or even 12 months as some limited data show that there is a difference in symptom persistence for subsequent concussions when the preceding concussion was more or less than 1 year prior.
Response: Our goal in setting the 3-month exclusion criterion was not to entirely rule out potential effects of previous concussion; in fact, we have an interest in exploring whether previous concussion is predictive of outcome. Instead, our goal was to exclude children who might still be in the acute phase of recovery from a previous concussion. Multiple previous studies show that the vast majority of children with concussion no longer show significant symptoms after 3 months, so this seemed like a reasonable cutoff. We will certainly examine whether the recency of previous concussion accounts for variation in outcome.
6) It is not clear that there is a measure of premorbid somatization tendencies which limited evidence suggest may be related to PCS reporting.
Response: The recent evidence regarding somatization as a predictor was not published at the time the study was being planned. However, our measures will provide us with indices of internalizing and perfectionism, both of which are likely to be related to somatization. 7) One concern is the duration and challenge of the testing strategy itself. Specifically, how will 90-120 minutes of testing influence some of the reported parameters among a population where cognitive exertion may exacerbate findings? Perhaps, this is another benefit of the orthopedic control group and therefore, a moot point.
Response: As the reviewer states, the assessment poses an equivalent burden for both groups. Perhaps more importantly, we are aware of no evidence showing that testing, even in the acute Emergency Department setting, exacerbates symptoms. Indeed, a recent publication by one of our colleagues shows that testing in the ED does not worsen symptoms (Brooks et al., J Neurotrauma, 33, 2091 -2096 . Nevertheless, we stop the assessment if a child becomes significantly more symptomatic during it, and will track the occurrence of such stoppages to determine if they occur more often in the concussion group.
8) The Dissemination Plan lacks some detail as to how results will be supplied to end users (bedside providers, policy drivers, professional societies) beyond traditional scientific results dissemination channels. Further description of the use of a "knowledge broker" in this document would be welcome if space permits Response: We have added some additional information about the role of the knowledge broker and our plans for knowledge translation with end users, as well as two pertinent references.
Reviewer 2 1) Following mTBI approximately 80% of subjects will return to baseline within 4-8 weeks. The focus of the genetic and imaging studies will therefore need to be on the 20% who will have ongoing symptoms.
Response: We agree that our focus in terms of prognosis will be on what differentiates those with ongoing symptoms from those without. Recent studies suggest that approximately 30% of children remain symptomatic at 4 weeks and about 10-15% at 3 months. The lower base rate of ongoing symptoms at later times is one of the reasons the study was designed with a large sample size.
2) In that regard the known predictors of ongoing symptoms include a history of anxiety and somatization which do not appear to be independently assessed using the most standardized neuropsychologic instruments (e.g., BAI-Y; BSI-18, respectively).
Response: The Strengths and Difficulties Questionnaire provides a measure of internalizing symptoms, as well as more general adjustment. Additionally, the Child-Adolescent Perfectionism Questionnaire provides a measure of perfectionism, which is closely related to anxiety.
3) The second MRI may not be warranted on subjects whose symptoms resolve in the first 2 to 4 weeks, who have normal MRIs at the first time point.
Response: Almost all MRIs will be "normal" in terms of having no visible lesions. The distinction between normality and abnormality on other quantitative analyses (e.g., DTI, resting state fMRI, MRS) is much less clear. Perhaps more importantly, concern is growing that some children may show quantitative differences on structural and functional MRI that persist past the resolution of symptoms. The second MRI at 3 or 6 months will allow us to determine if this is the case and for how long such differences are apparent. We have added text to that effect. 4) These investigators are appropriately looking for a history of headaches and migraines, as well as attention deficit and learning disability, which are independent predictors of adverse outcomes. However, two of the other known predictors of adverse outcomes following mTBI do not appear to be independently assessed. Since it has been shown that individuals with vestibulo-ocular deficits, as well as cervico-genic complications have prolonged symptoms of PCS, those assessments need to be made.
Response: Vestibulo-ocular and cervico-genic problems are themselves outcomes of trauma, and are often reflected in various symptoms (e.g., dizziness, dipolopia and other visual complaints, neck pain, balance problems). However, vestibulo-ocular and cervico-genic functions are difficult to measure accurately without time-consuming clinical assessments, and we did not want to introduce additional burden to the assessments given that they were not the focus of the study. We will only be able to assess vestibulo-ocular and cervico-genic problems indirectly, based on ratings of relevant postconcussive symptoms, as well as pain, and assessment of balance. 5) In a related concern, it would be important to identify the potential efficacy of any parallel therapy that each subject may be receiving. As mentioned, given the relevance of ongoing anxiety, vestibuloocular deficits, and cervico-genic pain in contributing to longer recovery periods, such subjects are often treated with ongoing behavioral therapy, vestibular therapy, and neck physical therapy, respectively. Subjects who receive such therapies will need to be identified, and have that information entered as a covariate, to establish the potential efficacy of such interventions in remediating ongoing symptoms.
Response: In the absence of random assignment, we cannot readily determine the effects of treatment. We cannot treat the provision of therapies simply as a covariate, because intervention is likely to be confounded with symptom status (i.e., children who are more symptomatic are more likely to receive intervention). However, we are tracking the interventions that children receive, and will consider analyzing the effect of treatment using statistical procedures such as propensity scores if sample sizes are sufficient. We now note in the Data Collection section that we are collecting this information.
We hope that you and the reviewers find the revised manuscript suitable for publication in BMJ Open. 
GENERAL COMMENTS
The authors have adequately addressed this reviewer's comments.
Of note, the sentence regarding the rationale for including an OI control group was not overlooked. I was merely hoping for slightly more detail in the explanation. However, as this is a standard comparator group for ED mTBI studies, this minor point should not preclude publication.
Thank you for allowing me the privilege of reviewing this study. The results are eagerly anticipated and urgently by both the mTBI research community and frontline providers charged with managing children with concussions. perhaps they are already committed to pursue this protocol, and they can'y make any changes...which gets to my original concern: this is not a research report...its is a description of a future protocol....which may not warrant publication as an original article in a research journal.
REVIEWER

VERSION 2 -AUTHOR RESPONSE -------------------------------------------------------------------------------Reviewer(s)' Comments to Author: -------------------------------------------------------------------------------Reviewer: 1
We have added a clause to indicate that the inclusion of children with orthopedic injuries helps to control for the general effects of trauma on symptom reporting and the non-speicfic nature of postconcussion symptoms.
We hope that you find the revised manuscript suitable for publication in BMJ Open.
